Vfend and alanine aminotransferase increased Patient Reports February 12, 2012

Vfend Side Effects Report #5061644-X
Vfend side effect was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased. Vfend dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5018330-1
Vfend side effect was reported by a Pharmacist from UNITED STATES on May 16, 2006. Female patient, 75 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, prothrombin time prolonged, red blood cell count decreased, treatment noncompliance. Vfend dosage: unknown. During the same period patient was treated with ZYVOX. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4909983-4
Vfend side effect was reported by a Physician from JAPAN on Jan 26, 2006. Male patient, 79 years of age, weighting 77.16 lb, was diagnosed with pulmonary mycosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood glucose increased, blood pressure decreased, blood pressure immeasurable, bradycardia, cardiac arrest , cerebrovascular disorder. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, HABEKACIN, MICAFUNGIN, MUCOSTA. Patient was hospitalized. Patient died on 09/17/2005.

Vfend Side Effects Report #4921188-X
Vfend side effect was reported by a Physician from JAPAN on Feb 07, 2006. Male patient, 79 years of age, weighting 77.16 lb, was diagnosed with pulmonary mycosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood glucose increased, blood pressure immeasurable, bradycardia, cardiac arrest , dyspnoea, haemoglobin decreased. Vfend dosage: 400 MG INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, HABEKACIN, MICAFUNGIN, MUCOSTA. Patient was hospitalized. Patient died on 09/17/2005.


Vfend Side Effects Report #4764742-0
Vfend side effect was reported by a Physician from JAPAN on Aug 26, 2005. Male patient, 72 years of age, was diagnosed with pulmonary mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, respiratory failure. Vfend dosage: 400 MG (200 MG, BID), ORAL. During the same period patient was treated with CYTOTEC, CLARITH, MUCODYNE, MUCOSOLVAN, SELBEX, PREDONINE, MEDICON, LAC B. Patient died on 07/29/2005.

Vfend Side Effects Report #4779009-4
Vfend side effect was reported by a Physician from JAPAN on Sept 12, 2005. Male patient was diagnosed with pneumonitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Vfend dosage: 360 MG INTRAVENOUS. During the same period patient was treated with MEROPEN, ADONA, TRANSAMIN, OMEPRAZOLE, STRONG NEO MINOPHAGEN C, NEORAL, MEDROL, MUCODYNE. Patient died on 09/01/2005.

Vfend Side Effects Report #5505656-8
Vfend side effect was reported by a Physician from JAPAN on Oct 22, 2007. Female patient, 48 years of age, was diagnosed with meningitis cryptococcal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood bilirubin increased, eyelid ptosis, jaundice , rash . Vfend dosage: unknown. During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5605279-6
Vfend side effect was reported by a Health Professional from FRANCE on Jan 16, 2008. Male patient, child 4 years of age, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. Patient recovered.

Vfend Side Effects Report #5619048-4
Vfend side effect was reported by a Health Professional from FRANCE on Jan 29, 2008. Male patient, child 4 years of age, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. Patient recovered.


Vfend Side Effects Report #5717062-1
Vfend side effect was reported by a Health Professional from FRANCE on Apr 14, 2008. Male patient, weighting 35.27 lb, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, PREDNISONE, PARACETAMOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5725389-2
Vfend side effect was reported by a Health Professional from FRANCE on Apr 23, 2008. Male patient, weighting 35.27 lb, was diagnosed with hepatosplenic candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, inflammation, pyrexia. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, SOLUPRED, PARACETAMOL, OMEPRAZOLE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5301407-0
Vfend side effect was reported by a Physician from JAPAN on Apr 06, 2007. Male patient, 73 years of age, weighting 99.21 lb, was diagnosed with fungal infection , bacterial infection , staphylococcal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, fungal infection , lymphoma , neoplasm malignant, pathogen resistance, staphylococcal infection . Vfend dosage: DAILY DOSE:300MG. During the same period patient was treated with BACTRIM, VANCOMYCIN. Patient died on 03/21/2007.

Vfend Side Effects Report #5104034-3
Vfend side effect was reported by a Physician from JAPAN on Aug 30, 2006. Male patient, 72 years of age, weighting 92.59 lb, was diagnosed with fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, delirium, dizziness , dysphagia, liver disorder, sepsis . Vfend dosage: 300 MG (150 MD, 2 IN 1 D), ORAL. During the same period patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, MUCODYNE, URSO, CLARITHROMYCIN, FLIVAS, AVISHOT, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/30/2006.

Vfend Side Effects Report #5131076-4
Vfend side effect was reported by a Physician from UNITED STATES on May 30, 2006. Female patient, 60 years of age, was diagnosed with fungal infection  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, jaundice cholestatic. Vfend dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.


Vfend Side Effects Report #4885958-9
Vfend side effect was reported by a Physician from JAPAN on Jan 05, 2006. Male patient, 59 years of age, weighting 138.9 lb, was diagnosed with fungal infection , acute myeloid leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, liver disorder, pulmonary veno-occlusive disease, weight increased. Vfend dosage: 400 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MYLOTARG, MICAFUNGIN, TIENAM, MIRIMOSTIM, STRONG NEO MINOPHAGEN C, CARBENIN, HABEKACIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #5079854-4
Vfend side effect was reported by a Physician from UNITED STATES on July 27, 2006. Male patient, 32 years of age, was diagnosed with fungal endocarditis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bicarbonate decreased, hypoventilation, lactic acidosis, tachypnoea. Vfend dosage: 200 MG (200 MG, 1 IN 1 D). During the same period patient was treated with MICOFUNGIN, AMIODARONE, DILANTIN. Patient recovered.

Vfend Side Effects Report #5131095-8
Vfend side effect was reported by a Physician from UNITED STATES on June 01, 2006. Male patient was diagnosed with fungal endocarditis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hallucination, visual disturbance. Vfend dosage: 400 MG (200 MG,2 IN 1 D). During the same period patient was treated with AMIODARONE, COUMADIN, ISORDIL, ZEBETA, POTASSIUM CHLORIDE, LANTUS, ALBUTEROL. Patient recovered.

Vfend Side Effects Report #4866926-X
Vfend side effect was reported by a Physician from JAPAN on Dec 14, 2005. Female patient, 66 years of age, was diagnosed with fungaemia, shock, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, pneumonia . Vfend dosage: 360 MG, INTRAVENOUS. During the same period patient was treated with COTRIM, CIPROFLOXACIN HYDROCHLORIDE, GANCICLOVIR. Patient died.

Vfend Side Effects Report #5150400-X
Vfend side effect was reported by a Pharmacist from JAPAN on Oct 25, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.


Vfend Side Effects Report #5167217-2
Vfend side effect was reported by a Physician from JAPAN on Nov 20, 2006. Male patient, 71 years of age, was diagnosed with eye infection fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ITRACONAZOLE. Patient recovered.

Vfend Side Effects Report #4800264-6
Vfend side effect was reported by a Physician from JAPAN on Sept 30, 2005. Male patient, 52 years of age, weighting 132.9 lb, was diagnosed with candida pneumonia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, hepatic function abnormal. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INRAVENOUS. During the same period patient was treated with DIFLUCAN, FUNGIZONE, PREDNISONE, NEORAL, FAMOTIDINE, SUCRALFATE, AMOBAN. Patient recovered.

Vfend Side Effects Report #4866912-X
Vfend side effect was reported by a Physician from JAPAN on Dec 14, 2005. Male patient, 75 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, liver disorder, night sweats. Vfend dosage: 400 MG (2 IN 1 D), ORAL. During the same period patient was treated with PERSELIN, GASTER, CLARITHROMYCIN, LOSARTAN POTASSIUM, ITRACONAZOLE, CALCIUM LACTATE, ALFAROL, MINPRESS. Patient recovered.

Vfend Side Effects Report #5044556-7
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, pneumonia , respiratory disorder. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.

Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain  and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.


Vfend Side Effects Report #6018843-X
Vfend side effect was reported by a Health Professional from JAPAN on Dec 11, 2008. Female patient was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, toxic epidermal necrolysis. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with ADONA, TRANSAMIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #6048343-2
Vfend side effect was reported by a Health Professional from JAPAN on Jan 13, 2009. Female patient was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, toxic epidermal necrolysis. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with ADONA, TRANSAMIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4896785-0
Vfend side effect was reported by a Physician from JAPAN on Jan 13, 2006. Female patient, 67 years of age, weighting 138.5 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection , cholestasis, condition aggravated, disseminated intravascular coagulation, duodenal perforation, fungal infection , hepatic function abnormal. Vfend dosage: 720 MG (360 MG, 2 IN 1D), INTRAVENOUS; 360 MG (180 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PREDNISONE, NIFEDIPINE, NIZATIDINE, LOXOPROFEN, UBIDECARENONE, MECOBALAMIN, TRIAZOLAM. Patient was hospitalized. Patient died on 12/08/2005.

Vfend Side Effects Report #5460895-X
Vfend side effect was reported by a Pharmacist from UNITED STATES on July 24, 2006. Female patient, 40 years of age, weighting 85.98 lb, was diagnosed with aspergillosis, asthma  and was treated with Vfend. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase, liver function test abnormal, nausea , vision blurred, visual disturbance. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4701784-5
Vfend side effect was reported by a Consumer or non-health professional from on June 14, 2005. Female patient, child 11 years of age, weighting 97.00 lb, was diagnosed with aspergillosis, leukaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain , blood alkaline phosphatase increased, blood bilirubin increased, bronchopulmonary aspergillosis, flushing, headache . Vfend dosage: 200 MG (100 MG 2 IN 1 D) INTRAVENOUS; 300 MG (150 MG 2 IN 1 D INTRAVENOUS). During the same period patient was treated with ASPARGINASE, MERCAPTOPURINE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Vfend Side Effects Report #5711728-5
Vfend side effect was reported by a Pharmacist from AUSTRALIA on Apr 09, 2008. Male patient, weighting 176.4 lb, was diagnosed with antifungal prophylaxis, evidence based treatment, pneumocystis jiroveci pneumonia and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anion gap increased, blood albumin decreased, blood alkaline phosphatase increased, blood bicarbonate increased, blood bilirubin increased, blood calcium decreased, blood creatine phosphokinase decreased, blood creatinine increased. Vfend dosage: unknown. During the same period patient was treated with BACTRIM, VINCRISTINE, PREDNISOLONE. Patient recovered.

Vfend Side Effects Report #5530943-7
Vfend side effect was reported by a Pharmacist from UNITED STATES on Nov 20, 2007. Male patient, 62 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, blood creatine phosphokinase increased, chronic obstructive pulmonary disease, cytomegalovirus infection , ill-defined disorder, staphylococcal infection . Vfend dosage: unknown. During the same period patient was treated with VYTORIN. Patient was hospitalized. Patient recovered.

Vfend Side Effects Report #4866806-X
Vfend side effect was reported by a Physician from JAPAN on Dec 13, 2005. Female patient was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pulmonary veno-occlusive disease. Vfend dosage: 4 MG/KG (1 IN 1D) INTRAVENOUS. During the same period patient was treated with MYLOTARG. Patient recovered.